Financials
- Market Capitalization 1.84 B
- Employee 72
- Founded 2020
- CEO N/A
- Website www.hemab.com
- Headquarter Delaware, United States
- FIGI BBG021LKFW00
- Industry N/A
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1973 | MGRT Mega Fortune Company Limited | 135.00 USD | +0.87% | +12.50% | +18.95% | -80.41% | 1.86 B USD | ||
| 1983 | ALMR Alamar Biosciences, Inc. Common Stock | 26.48 USD | -7.67% | -13.01% | -14.58% | +17.17% | 1.84 B USD | ||
| 1988 | BRVE Braveheart Bio, Inc. Common Stock | 20.3900 USD | +5.81% | +1.75% | -3.55% | -32.48% | 1.83 B USD | ||
| 2022 | TRAX First Tracks Biotherapeutics, Inc. Ordinary Shares | 41.64 USD | -6.34% | -10.49% | -1.49% | +103.02% | 1.75 B USD |
Frequently asked questions about Hemab Therapeutics Holdings, Inc. Common Stock
What is the Hemab Therapeutics Holdings, Inc. Common Stock stock price today?
The current price of Hemab Therapeutics Holdings, Inc. Common Stock (COAG) is 39.29. Over the past 24 hours, the stock has changed by -1.43%. Follow the COAG chart for real-time price dynamics.
What is the stock ticker of Hemab Therapeutics Holdings, Inc. Common Stock?
Hemab Therapeutics Holdings, Inc. Common Stock trades under the ticker COAG. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Hemab Therapeutics Holdings, Inc. Common Stock stock going up?
COAG has changed by -5.33% over the last week, +11.62% over the last month, and +45.52% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Hemab Therapeutics Holdings, Inc. Common Stock?
Hemab Therapeutics Holdings, Inc. Common Stock currently has a market capitalization of 1.84 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Hemab Therapeutics Holdings, Inc. Common Stock earnings last quarter?
Last quarter, Hemab Therapeutics Holdings, Inc. Common Stock reported earnings of -0.58 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Hemab Therapeutics Holdings, Inc. Common Stock revenue for the last quarter?
Hemab Therapeutics Holdings, Inc. Common Stock reported quarterly revenue of 500 K. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Hemab Therapeutics Holdings, Inc. Common Stock net income for the last quarter?
Hemab Therapeutics Holdings, Inc. Common Stock reported net income of 27.3 M for the last quarter. The previous quarter showed -24.15 M, which means net income changed by +213.06%.
How many employees does Hemab Therapeutics Holdings, Inc. Common Stock have?
As of the latest available data, Hemab Therapeutics Holdings, Inc. Common Stock has 72 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Hemab Therapeutics Holdings, Inc. Common Stock stock?
You can buy Hemab Therapeutics Holdings, Inc. Common Stock (COAG) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Hemab Therapeutics Holdings, Inc. Common Stock stock?
Investing in Hemab Therapeutics Holdings, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the COAG chart and related analysis on metatrader.com as part of your research.